Glucagon‐like peptide‐1 receptor agonists (GLP‐1 RAs) are commonly used for Type 2 diabetes mellitus (T2DM) and obesity. The gene discussed is GLP1R; the disease is obesity due to melanocortin 4 receptor deficiency.